Embase for drug analytics
Biomedical literature has a critical role in post-market surveillance and vigilance to ensure the safety and effectiveness of drugs and medical devices. In the meantime, data extracted from the literature is being more used in different stages of drug discovery and development to achieve different goals. Understanding the relationship between drug-disease, drug-drug, device-disease and device-device can provide important insights for drug development and re-positioning.
In this webinar, Quality Control Scientist Dr. Erin van Buel will discuss
- Indexing principles and relationships identified with in-depth indexing in Embase
- How to use advanced search filters and features to identify semantic relationships between drugs and diseases, such as drugs used to treat a disease, drug-drug combination, drug-drug interaction, etc.
- How the semantic relationships identified with in-depth indexing can be used to inform drug development, re-positioning and safety
Related whitepapers, case studies, etc.
Elsevier's Life Science Solutions,COVID-19 search strategies in PharmaPendium: Focus on DMPK and DDIs
17 September 2020
COVID-19 search strategies in PharmaPendium: Focus on drug safety and efficacy
10 September 2020
Text mining as a solution: Find disease-related genetic variation in literature
2 September 2020
Webinars that may also interest you
Scopus,Researchers: CiteScore 2019 and the responsible use of metrics
Hans Zijlstra (Research Metrics Product Manager) and Aileen Christensen (Senior Marketing Manager)
29 June 2020
The many helpful applications of journal impact metrics
Hans Zijlstra (Product Manager, Research Metrics) and Aileen Christensen (Senior Marketing Manager)
24 June 2020
Scopus APIs: Getting started with Scopus search
Martin Edling Andersson, Principal Product Manager and Aileen Christensen, Senior Marketing Manager
23 June 2020